{
  "resourceType": "DiagnosticReport",
  "id": "dr-sarah-obrien-preeclampsia-panel-2026-02-15",
  "status": "final",
  "category": [
    {
      "coding": [
        {
          "system": "http://terminology.hl7.org/CodeSystem/v2-0074",
          "code": "LAB",
          "display": "Laboratory"
        }
      ]
    }
  ],
  "code": {
    "coding": [
      {
        "system": "http://loinc.org",
        "code": "89044-0",
        "display": "Preeclampsia evaluation panel"
      }
    ],
    "text": "Preeclampsia evaluation panel"
  },
  "subject": {
    "reference": "Patient/patient-sarah-obrien"
  },
  "encounter": {
    "reference": "Encounter/encounter-sarah-obrien-2026-02-15"
  },
  "effectiveDateTime": "2026-02-15T08:00:00Z",
  "issued": "2026-02-15T10:30:00Z",
  "result": [
    {
      "reference": "Observation/obs-sarah-obrien-platelets-2026-02-15",
      "display": "Platelets 98 x10^3/uL [L]"
    },
    {
      "reference": "Observation/obs-sarah-obrien-creatinine-2026-02-15",
      "display": "Creatinine 1.1 mg/dL [H]"
    },
    {
      "reference": "Observation/obs-sarah-obrien-uric-acid-2026-02-15",
      "display": "Uric Acid 7.8 mg/dL [H]"
    },
    {
      "reference": "Observation/obs-sarah-obrien-alt-2026-02-15",
      "display": "ALT 52 U/L [H]"
    },
    {
      "reference": "Observation/obs-sarah-obrien-ast-2026-02-15",
      "display": "AST 48 U/L [H]"
    },
    {
      "reference": "Observation/obs-sarah-obrien-protein-cr-ratio-2026-02-15",
      "display": "Protein/Creatinine Ratio 0.45 mg/mg [H]"
    }
  ],
  "conclusion": "Laboratory findings consistent with severe preeclampsia in the setting of elevated blood pressure (168/108 mmHg at 34 weeks gestation). Thrombocytopenia (platelets 98K) suggests evolving HELLP spectrum. Elevated creatinine (1.1 mg/dL) and uric acid (7.8 mg/dL) indicate renal involvement. Transaminitis (ALT 52, AST 48 U/L) confirms hepatic involvement. Significant proteinuria (protein/creatinine ratio 0.45) confirms renal protein wasting. Findings warrant close monitoring for HELLP syndrome progression and consideration of delivery timing."
}
